MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
National Research Corporation Operating Cycle 2011-2026 | NRC
Annual Operating Cycle National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.4 | 29.9 | 33 | 33.9 | 34.1 | 35 | 33.4 | 37.4 | 47.1 | 41.5 | 40.7 | 38.4 | 49.6 | - | - | 26.4 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.6 | 26.4 | 36.4 |
Quarterly Operating Cycle National Research Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 33.2 | 31.8 | 30.4 | - | 26.9 | - | - | - | 31.7 | 32.9 | 35.9 | - | 18.6 | 19.5 | 35.2 | - | 36.8 | 35.6 | 36.3 | - | 38 | 40.8 | 34.4 | - | 32.7 | 33.8 | 34.1 | - | 36.2 | 38.8 | 39.3 | - | 46.7 | 47.5 | 38.7 | - | 36.7 | 38 | 33.8 | - | 35.5 | 36.6 | 31.1 | - | 31.3 | 30.9 | 33.6 | - | 45 | 45.1 | 42.4 | - | 51.7 | 53.6 | 47.5 | - | 55 | 55.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 55.7 | 18.6 | 37.4 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
97.4 | $ 22.01 | -11.09 % | $ 638 M |  USA |
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 17.01 | - | $ 179 M |  China |
 |
Agilent Technologies
A
|
161 | $ 118.28 | 0.43 % | $ 36 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 21.69 | 3.53 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 1.65 | 0.61 % | $ 2.19 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 428.82 | 0.48 % | $ 12.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 187.3 | 3.06 % | $ 9.28 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
95.1 | $ 4.17 | 1.34 % | $ 386 M | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
102 | $ 8.99 | 1.07 % | $ 1.15 B | USA |
 |
Natera
NTRA
|
81.5 | $ 216.86 | 0.82 % | $ 21.3 B | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 14.8 | -0.8 % | $ 447 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.58 | 1.4 % | $ 26.2 B |  Niderland |
 |
Guardant Health
GH
|
128 | $ 90.9 | -1.46 % | $ 11.4 B | USA |
 |
Personalis
PSNL
|
55.8 | $ 6.12 | 0.82 % | $ 363 M | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 124.97 | 0.68 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
198 | $ 138.93 | -2.56 % | $ 22.1 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.94 | -0.01 % | $ 2.69 B | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 5.3 | -1.12 % | $ 221 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 2.04 | -3.33 % | $ 9.02 M | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
204 | $ 2.19 | -0.9 % | $ 5.03 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 472.26 | -0.23 % | $ 178 B | USA |
 |
Lantheus Holdings
LNTH
|
121 | $ 90.2 | 4.7 % | $ 6.09 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.61 | 1.72 % | $ 219 M | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 256.45 | -0.19 % | $ 21.3 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 59.1 | -0.72 % | $ 3.53 B | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 9.14 | -0.44 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 188.42 | -0.38 % | $ 20.9 B | USA |
 |
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | USA |